Li, W., Kang, Z., Li, C., Li, Y., Wu, S., Gao, X., Lei, T., Liu, Y., Yan, Y., Wu, L., Chen, B., Chen, Z., Huang, W., Li, N., Shu, K., Zhang, Y., Ma, W., Tang, B., Liu, Y., Zhou, Y. (2026). Luvometinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas: A randomized, double-blind, placebo-controlled, phase 3 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3017